1. Home
  2. POCI vs INKT Comparison

POCI vs INKT Comparison

Compare POCI & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

HOLD

Current Price

$4.15

Market Cap

32.4M

Sector

Health Care

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

N/A

Current Price

$11.91

Market Cap

51.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POCI
INKT
Founded
1982
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4M
51.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
POCI
INKT
Price
$4.15
$11.91
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
21.4K
19.9K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,575,039.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.67
N/A
52 Week Low
$3.77
$4.56
52 Week High
$5.34
$76.00

Technical Indicators

Market Signals
Indicator
POCI
INKT
Relative Strength Index (RSI) 42.98 47.84
Support Level $4.05 $11.55
Resistance Level $4.30 $12.68
Average True Range (ATR) 0.23 0.83
MACD -0.01 0.08
Stochastic Oscillator 25.63 49.47

Price Performance

Historical Comparison
POCI
INKT

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: